TXA synthase (F456) Peptide 
Datasheet
COA
MSDS
SHIP
Product Name :
TXA synthase (F456) Peptide Applications :
Blocking Background :
TXA synthase, also referred to as thromboxane synthase or CYP5, is an enzyme that catalyzes the conversion of the prostaglandin endoperoxide (PGH2) into Thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. TXA synthase is an important part of the cytochrome P450 system. Thromboxane A2 plays a pivotal role in the maintenance of hemostasis and cardiovascular diseases along with Prostacyclin. The expression of TXA synthase has been found to be consistently upregulated in several types of cancer tissues suggesting the involvement of this enzyme in tumor growth in humans. Thromboxanes are produced by TXA synthase in excess in inflammatory bowel disease. Alternative Name :
BDPLT14; CYP5; CYP5A1; Cytochrome P450 5A1; Cytochrome P450; family 5; subfamily A; polypeptide 1; FLJ52771; GHOSAL; Platelet cytochrome P450 subfamily V; TBXAS1; THAS; THAS; Thromboxane A synthase 1 (platelet); Thromboxane A synthase 1 (platelet; cytochrome P450; family 5; subfamily A); Thromboxane A synthase 1; Thromboxane A synthase 1 platelet cytochrome P450 subfamily V; Thromboxane-A synthase; TS; TXA synthase; TXAS; TXS; Swiss-Prot :
P24557 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide TXA synthase (F456). (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS9278 TXA synthase (F456) pAb.
TXA synthase (F456) Peptide Applications :
Blocking Background :
TXA synthase, also referred to as thromboxane synthase or CYP5, is an enzyme that catalyzes the conversion of the prostaglandin endoperoxide (PGH2) into Thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. TXA synthase is an important part of the cytochrome P450 system. Thromboxane A2 plays a pivotal role in the maintenance of hemostasis and cardiovascular diseases along with Prostacyclin. The expression of TXA synthase has been found to be consistently upregulated in several types of cancer tissues suggesting the involvement of this enzyme in tumor growth in humans. Thromboxanes are produced by TXA synthase in excess in inflammatory bowel disease. Alternative Name :
BDPLT14; CYP5; CYP5A1; Cytochrome P450 5A1; Cytochrome P450; family 5; subfamily A; polypeptide 1; FLJ52771; GHOSAL; Platelet cytochrome P450 subfamily V; TBXAS1; THAS; THAS; Thromboxane A synthase 1 (platelet); Thromboxane A synthase 1 (platelet; cytochrome P450; family 5; subfamily A); Thromboxane A synthase 1; Thromboxane A synthase 1 platelet cytochrome P450 subfamily V; Thromboxane-A synthase; TS; TXA synthase; TXAS; TXS; Swiss-Prot :
P24557 Product :
1 mg/ml in DI water. Purification&Purity :
Synthetic peptide TXA synthase (F456). (Note: the amino acid sequence is proprietary). The purity is > 98%. Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
This peptide can be used with studies using BS9278 TXA synthase (F456) pAb.
Blocking peptide available as BS9278PP